Replies to post #87218 on Niocorp Developments Ltd (NB)

[MaxzMillionz]

Celularity has continued to burn hemorrhage cash and issue private placements after the SPAC. If I remember correctly they just recently kicked off their first clinical trial. The success of the SPAC depends on the company they buy or in the NioCorp case merge with. Celularity is not at all an apples to apples comparison, but you are a smart guy so I’m sure you know that.

[AlwaysOptimistic]

JMO, but, this merger could be more about joining NASDAQ and attracting institutional investors who can't buy NioCorp today because it is a penny stock. That is a benefit to both NioCorp and GX shareholders.

NASDAQ, based in New York City is the World's 2nd largest stock exchange by market cap of listed companies with a market cap of 17.23 Trillion. Only the NYSE is larger with a 22.1 Trillion market cap.

Enclosed is the complete list:

https://www.statista.com/statistics/270126/largest-stock-exchange-operators-by-market-capitalization-of-listed-companies/#:~:text=The%20New%20York%20Stock%20Exchange,What%20is%20a%20stock%20exchange%3F